However, Tegtmeyer said it's not necessarily time to call it quits for investigating aspirin in this setting. "This was a small study," he told MedPage Today. "The use of 200 mg of aspirin daily may ...

Patients were randomly assigned in a 1:1 ratio to receive either aspirin 200 mg daily or a placebo for three years. Follow-up spanned five years, with regular clinical visits and recommended ...

Daily aspirin use after standard adjuvant therapy did not improve DFS for patients with colorectal cancer, according to ...

A large trial shows aspirin does not significantly improve disease-free survival in patients with high-risk colorectal cancer ...

However, Tegtmeyer said it's not necessarily time to call it quits for investigating aspirin in this setting. "This was a small study," he told MedPage Today. "The use of 200 mg of aspirin daily ...